ストックスクリーナーアプリを入手
0.6552
14.49%
-0.111
前日終値:
$0.7662
開ける：
$0.7821
24時間の取引高:
2.12M
Relative Volume:
0.47
時価総額：
$43.17M
収益：
-
当期純損益:
$-86.08M
株価収益率:
-0.3037
EPS:
-2.1574
ネットキャッシュフロー:
$-72.06M
1週間 パフォーマンス:
+18.67%
1か月 パフォーマンス:
-61.68%
6か月 パフォーマンス:
-23.82%
1年 パフォーマンス:
-45.85%
1日の値動き範囲:
$0.62
$0.7856
1週間の範囲:
$0.55
$0.7856
52週間の値動き範囲:
$0.3234
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
IOBT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.6552 | 50.48M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | ダウングレード | TD Cowen | Buy → Hold |
Io Biotech Inc (IOBT) 最新ニュース
How IO Biotech Inc. stock reacts to bond yieldsSwing Trade & Risk Managed Investment Signals - Trung tâm Dự báo KTTV quốc gia
How IO Biotech Inc. stock reacts to global recession fearsJuly 2025 Fed Impact & Verified Chart Pattern Signals - Trung tâm Dự báo KTTV quốc gia
How hedge fund analytics apply to IO Biotech Inc. stockIPO Watch & Low Drawdown Investment Strategies - newser.com
Is IO Biotech Inc. stock near bottom after decline2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Key resistance and support levels for IO Biotech Inc.July 2025 Momentum & Community Supported Trade Ideas - newser.com
Can momentum traders help lift IO Biotech Inc.Treasury Yields & Fast Gaining Stock Reports - newser.com
Applying chart zones and confluence areas to IO Biotech Inc.Portfolio Gains Report & Risk Controlled Daily Plans - newser.com
Will IO Biotech Inc. stock outperform tech sector in 2025July 2025 PostEarnings & Precise Buy Zone Identification - newser.com
IO Biotech announces up to €57.5M debt financing from the European Investment Bank - MSN
Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Has IO Biotech Inc. found a price floorFed Meeting & AI Powered Buy and Sell Recommendations - newser.com
IO Biotech Inc. stock prediction for this weekMarket Volume Report & Weekly High Return Stock Forecasts - newser.com
Layoff Tracker: Ferring To Cut 500 Employees as Part of Business Model Shift - BioSpace
Candlestick signals on IO Biotech Inc. stock today2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
Does IO Biotech Inc. qualify in momentum factor screeningRisk Management & Verified Technical Signals - newser.com
Multi asset correlation models including IO Biotech Inc.Market Performance Recap & Growth Oriented Trading Recommendations - newser.com
Tick level data insight on IO Biotech Inc. volatilityEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion - Sahm
How sentiment analysis helps forecast IO Biotech Inc.Earnings Performance Report & Risk Managed Trade Strategies - newser.com
What does recent volatility data suggest for IO Biotech Inc.July 2025 Setups & Consistent Growth Equity Picks - newser.com
Analysts Set IO Biotech, Inc. (NASDAQ:IOBT) Price Target at $8.00 - Defense World
IO Biotech (NASDAQ:IOBT) Downgraded to Equal Weight Rating by Morgan Stanley - Defense World
IO Biotech’s (IOBT) Hold Rating Reaffirmed at TD Cowen - Defense World
IO Biotech (IOBT) Downgraded to Hold by TD Cowen | IOBT Stock Ne - GuruFocus
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says - MarketScreener
IO Biotech Feels The Heat As US FDA Dashes Cylembio Filing Hopes - insights.citeline.com
IO Biotech (NASDAQ:IOBT) Receives "Hold" Rating from TD Cowen - MarketBeat
TD Cowen Maintains IO Biotech(IOBT.US) With Hold Rating - 富途牛牛
TD Cowen Downgrades IO Biotech to Hold From Buy - MarketScreener
FDA Recommends Against IO Biotech’s Cylembio Application - The Globe and Mail
Io Biotech Inc (IOBT) 財務データ
収益
当期純利益
現金流量
EPS
1.84%
0.50%
大文字化:
|
ボリューム (24 時間):